Mesothelioma Cancer Centers
Winship Cancer Institute of Emory University
Doctors Affiliated with this Treatment Facility
If you have been told you have asbestos cancer (such as pericardial mesothelioma and peritoneal mesothelioma), you would be wise to consider several factors before choosing which cancer center or treatment program might be best for you. The number of alternatives for mesothelioma treatment is constantly rising as scientists learn more about malignant mesothelioma and as pharmaceutical companies perform clinical trials on newly developed cancer-fighting drugs. As a result, general practitioners and smaller, community hospitals might not possess the expertise and experience needed to provide the most effective care for those who have mesothelioma. In addition, it's also wise to choose a facility run by caring professionals who will take the time to explain the treatment options and with whom you and your family are comfortable. Some regions of the country don't have state-of-the-art facilities for hard-to-treat diseases such as pleural mesothelioma, in which case you may be required to travel so as to obtain the highest chance of remission.
The Winship Cancer Institute was founded in 1937. It was recently designated as a Comprehensive Cancer Center by the National Cancer Institute (NCI), it is one of only thirty-nine cancer treatment facilities in the U.S. to have such designation. It has also been named as a Blue Distinction Center for Complex and Rare Cancers by Blue Cross and Blue Shield of Georgia. Most recently, the Winship Institute was awarded a five-year, $12.5 million Specialized Program of Research Excellence (SPORE) grant, the first institute in the state of Georgia to be awarded such funds.
In 2004, Winship received a $10 million grant from the National Institute of Health for the study of nanotechnology (microscopic machines) and their use in the treatment of prostate cancer.
The Winship Cancer Institute currently has four full scientific programs with several more in development. Each program is run by researchers whose interests in a specific area are complementary and synergistic. Some of these are:
- Cancer Control and Population Sciences
- Cancer Genetics and Epigenetics (CGE)
- Discovery & Developmental Therapeutics
- Molecular Pathways & Biomarkers
Author: Linda Molinari
Editor in Chief, Mesothelioma Cancer AllianceRead about Linda
Reviewer: Annette Charlevois
Patient Support CoordinatorRead about Annette
Winship Cancer Institute Website